TEAM

 

Prof. Luca CasettariUniversità di Urbino

 

 

 

Prof. Dritan HasaUniversità di Trieste

 

 

 

Prof. Cinzia PaganoUniversità di Perugia

 

 

 

Dr. Angela AbruzzoUniversità di Bologna

 

 

 

 

PROJECT

The development of age-appropriate and personalized formulations is still a necessity. Antibiotic medicines present a series of significant drawbacks due to the lack of specific studies in the different stages of the development of new oral dosage forms. Indeed, when it comes to therapeutic treatments it is nowadays widely accepted that the pediatric population has different needs from adults.

This project will explore and combine innovative strategies to obtain suitable oral antibiotic formulations, specifically designed for various pediatric age groups, through the advancement of new approaches for personalized medicine.

The goal is improving safety, efficacy, and acceptability, thus fulfilling specific pharmaceutical requirements such as bioavailability, dose uniformity, ease and safe administration.

p3Diatrics will impact current clinical scenarios by providing personalized therapies that, combined with an innovative approach from the materials science and formulation technology fields, represent an important step forward for the improvement of pharmacological compliance in pediatric antibiotic treatments.

 

Industrial interest

MB Therapeutics